The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors.

MLA

Waissengein, Barliz, et al. “The Predictive Value of High Sensitivity Troponin Measurements in Patients Treated with Immune Checkpoint Inhibitors.” Clinical Research in Cardiology : Official Journal of the German Cardiac Society, vol. 112, no. 3, Mar. 2023, pp. 409–18. EBSCOhost, https://doi.org/10.1007/s00392-022-02118-8.

APA

Waissengein, B., Abu Ata, B., Merimsky, O., Shamai, S., Wolf, I., Arnold, J. H., Bar-On, T., Banai, S., Khoury, S., & Laufer-Perl, M. (2023). The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors. Clinical Research in Cardiology : Official Journal of the German Cardiac Society, 112(3), 409–418. https://doi.org/10.1007/s00392-022-02118-8

Chicago

Waissengein, Barliz, Bian Abu Ata, Ofer Merimsky, Sivan Shamai, Ido Wolf, Joshua H Arnold, Tali Bar-On, Shmuel Banai, Shafik Khoury, and Michal Laufer-Perl. 2023. “The Predictive Value of High Sensitivity Troponin Measurements in Patients Treated with Immune Checkpoint Inhibitors.” Clinical Research in Cardiology : Official Journal of the German Cardiac Society 112 (3): 409–18. doi:10.1007/s00392-022-02118-8.